Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: A multicenter cross-sectional study

International Journal of Gynecological Pathology

Volumn 30, Issue 2, 2011, Pages 173-184

  Roteli Martins, Cecilia M ^a   De Carvalho, Newton S ^b   Naud, Paulo ^c   Teixeira, Julio ^d   Borba, Paola ^d   Derchain, Sophie ^e,f   Tyring, Stephen ^g   Gall, Stanley ^h   Diaz, Angela ⁱ   Blatter, Mark ^j   Shier, Robert M ^o   Romanowski, Barbara ^k   Quint, Wim G V ^l   Issam, Jamiai ^m   Galindo, Claudia ⁿ   Schuind, Anne ⁿ   Dubin, Gary ⁿ  

^a Parana Federal University   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d UNIVERSITY OF FORTALEZA   (Brazil)

^e UNIVERSITY OF CAMPINAS   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF TEXAS   (United States)

^h University of Louisville School of Medicine   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j Primary Physicians Research   (United States)

^k UNIVERSITY OF ALBERTA   (Canada)

^l DDL DIAGNOSTIC LABORATORY   (Netherlands)

^m GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

ⁿ GLAXOSMITHKLINE   (United States)

^o UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Cytology; Human papillomavirus; Prevalence; Risk factor

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BRAZIL; CANADA; CANCER RISK; CYTOLOGY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFECTION RISK; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UNITED STATES;

ADOLESCENT; ADULT; BRAZIL; CANADA; CROSS-SECTIONAL STUDIES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; UNITED STATES; UTERINE CERVICAL DISEASES; YOUNG ADULT;

EID: 79951773627     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181f38dfe     Document Type: Article

References (45)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9. (Pubitemid 29406813)
2. Bosch FX, Munoz N. The viral etiology of cervical cancer. Virus Res 2002;89:183-90. (Pubitemid 35351537)
3. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278-85.
4. De Sanjosé S, Quint W, Klaustemeier J, et al. HPV type distribution in invasive cervical cancer: The worldwide perspective. Proceedings of the 24th International Papillomavirus Conference and Clinical Workshop, Beijing, China 2007; Abstract 2C-01.
5. Clifford G, Franceschi S. Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer 2008;122:1684-5. (Pubitemid 351294981)
6. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8. (Pubitemid 28135669)
7. Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218-26. (Pubitemid 36152435)
8. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6. (Pubitemid 32539115)
9. Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005;337:76-84. (Pubitemid 40725441)
10. Castle PE, Schiffman M, Herrero R, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005;191: 1808-16. (Pubitemid 40705386)
11. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072-9. (Pubitemid 41417924)
12. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006;24(suppl 3):S11-S25. (Pubitemid 44404053)
13. de Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007;7:453-9.
14. Franceschi S, Clifford GM. Re: a study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst 2005;97:938-9.
15. Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and typespecific implications in cervical neoplasia. Vaccine 2008; 26(suppl 10):K1-16.
16. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285:2995-3002. (Pubitemid 32550118)
17. Giuliano AR, Papenfuss M, Abrahamsen M, et al. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border. Cancer Epidemiol Biomarkers Prev 2002;11:930-4. (Pubitemid 35014900)
18. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-14. (Pubitemid 34016525)
19. Ho GY, Studentsov Y, Hall CB, et al. Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 viruslike particles. J Infect Dis 2002;186:737-42. (Pubitemid 35013424)
20. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003;12: 485-90. (Pubitemid 36713640)
21. Rousseau MC, Franco EL, Villa LL, et al. A cumulative casecontrol study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer Epidemiol Biomarkers Prev 2000;9:469-76. (Pubitemid 30313889)
22. Sellors JW, Karwalajtys TL, Kaczorowski J, et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003;168:421-5. (Pubitemid 36255727)
23. Trottier H, Franco EL. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Am J Manag Care 2006;12:S462-72. (Pubitemid 46053397)
24. Franco EL, Villa LL, Ruiz A, et al. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995;172:756-63.
25. Kjaer SK, van den Brule AJ, Bock JE, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997;6:799-805.
26. Richardson H, Franco E, Pintos J, et al. Determinants of lowrisk and high-risk cervical human papillomavirus infections in Montreal University students. Sex Transm Dis 2000;27:79-86. (Pubitemid 30082877)
27. Kleter B, van Doorn LJ, ter Schegget J, et al. Novel shortfragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-9. (Pubitemid 28550661)
28. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37:2508-17. (Pubitemid 29337270)
29. van Doorn LJ, Molijn A, Kleter B, et al. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol 2006;44:3292-8. (Pubitemid 44413767)
30. Baay MF, Quint WG, Koudstaal J, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin- embedded cervical carcinomas. J Clin Microbiol 1996;34: 745-7. (Pubitemid 26065812)
31. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004;364:1757-65. (Pubitemid 39488060)
32. Castellsague X, de Sanjose S, Aguado T, et al. HPV and Cervical Cancer in the World. 2007 Report. Vaccine 2007;25: C1-230.
33. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180:1415-23. (Pubitemid 29506440)
34. Manhart LE, Holmes KK, Koutsky LA, et al. Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy. Sex Transm Dis 2006;33:502-8. (Pubitemid 44126894)
35. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-9. (Pubitemid 46333946)
36. Cuschieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004;57:68-72. (Pubitemid 38091314)
37. Chang DY, Chen RJ, Lee SC, et al. Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia. J Med Microbiol 1997;46:54-60. (Pubitemid 27019748)
38. Chaturvedi AK, Myers L, Hammons AF, et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 2005; 14:2439-45. (Pubitemid 41437849)
39. Carter JJ, Koutsky LA, Hughes JP, et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000;181:1911-9. (Pubitemid 30416152)
40. Vaccarella S, Franceschi S, Herrero R, et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006;15:326-33. (Pubitemid 43342183)
41. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-54.
42. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A metaanalysis. Sex Transm Dis 2002;29:725-35. (Pubitemid 35266418)
43. Vaccarella S, Herrero R, Dai M, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006;15: 2148-53. (Pubitemid 44877039)
44. Nielsen A, Kjaer SK, Munk C, et al. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis 2008;35:276-82. (Pubitemid 351619532)
45. Giuliano AR, Papenfuss M, De Galaz EM, et al. Risk factors for squamous intraepithelial lesions (SIL) of the cervix among women residing at the US-Mexico border. Int J Cancer 2004;109:112-18. (Pubitemid 38160670)